What's Happening?
CoapTech, a medical technology company specializing in ultrasound-guided solutions, has announced a leadership transition with the appointment of Brad Kreger as Chief Executive Officer. Kreger succeeds
Howard Carolan, CoapTech's Co-Founder and former CEO, who will remain as an advisor to ensure a smooth transition. Kreger brings extensive experience in medical device manufacturing and has previously held leadership roles at Velo3D, Fluidigm Corporation, Thermo Fisher Scientific, and Affymetrix Inc. The transition is aimed at accelerating CoapTech's growth and expanding the adoption of its percutaneous ultrasound gastrostomy technology across various healthcare settings.
Why It's Important?
The leadership change at CoapTech is crucial for the company's strategic direction and growth. Brad Kreger's appointment is expected to drive the company's expansion efforts and enhance its market presence in the medical technology sector. His background in scaling organizations and commercializing high-demand services positions CoapTech to capitalize on emerging opportunities in the healthcare industry. The transition also underscores the importance of leadership in navigating the complexities of medical device innovation and adoption. As CoapTech seeks to expand access to its technology, the leadership change could have significant implications for patient outcomes and healthcare provider efficiency.
